When electronic cigarettes first appeared around 2010, they were widely described as a breakthrough in tobacco harm reduction. The idea seemed straightforward: deliver nicotine without the tar and toxic combustion products produced by burning tobacco. Public health authorities cautiously supported vaping as a possible tool to help smokers quit. Early messaging even suggested that vaping might be about 95% less harmful than traditional cigarettes.
More than a decade later, however, the picture is becoming more complicated.
A growing body of research suggests that vaping carries its own set of health risks—some already measurable and others still uncertain. While most experts still believe vaping is likely less harmful than smoking cigarettes, the emerging evidence shows that “less harmful” should not be confused with “safe.”
Recent research has begun to raise concerns about vaping’s effects on the cardiovascular system. One study published in the American Journal of Physiology – Heart and Circulatory Physiology found that people who vape or smoke have nearly 50% higher odds of elevated blood pressure compared with people who use neither product. This finding does not prove that vaping directly causes high blood pressure, since factors such as diet, weight, and exercise also affect cardiovascular health. Still, it adds to a growing pattern of evidence suggesting that nicotine delivery through vaping may strain the heart and blood vessels.
The biological mechanisms behind this concern are not particularly mysterious. Nicotine itself is a stimulant that triggers immediate increases in heart rate and blood pressure. In addition, the flavorings and chemical compounds present in e-cigarette vapor can irritate or damage the lining of blood vessels, a layer of tissue that plays a critical role in regulating blood flow and preventing clot formation. Damage to this lining—known as the endothelium—is a known early step in the development of cardiovascular disease.
Respiratory health is another area where research is beginning to reveal troubling signals. Studies comparing smokers, vapers, and non-users have found that people who vape can show reduced lung function along with higher rates of coughing, wheezing, and bronchitis-like symptoms. Some research conducted between 2023 and 2025 has also linked vaping with increased airway resistance and flare-ups of asthma symptoms, suggesting that the lungs may remain irritated even after a vaping session ends.
These findings challenge the early perception that inhaling vapor is largely harmless compared with inhaling smoke. While vapor does eliminate many of the toxic chemicals created by burning tobacco, it still delivers a mixture of substances whose long-term effects are not fully understood.
Perhaps the most urgent public-health concern involves young people. Over the past decade, vaping has spread rapidly among teenagers and young adults. The World Health Organization now warns that e-cigarettes are “harmful and not safe,” particularly for youth. Research suggests that teenagers who vape may be several times more likely to begin smoking traditional cigarettes later on, raising concerns that vaping could act as a gateway into nicotine addiction rather than an exit from it.
Nicotine exposure during adolescence is especially troubling because the brain continues developing into the mid-twenties. Nicotine can alter neural pathways involved in attention, learning, and impulse control. Large surveys have also found links between youth vaping and increased reports of anxiety, depression, and suicidal thoughts, although these associations remain the subject of ongoing research.
Supporters of vaping argue—often with some justification—that these risks must be weighed against the enormous harm caused by cigarettes. Tobacco smoking remains one of the leading causes of preventable death worldwide, responsible for millions of deaths each year. Some studies show that vaping can help certain adult smokers quit, particularly when it is combined with counseling or other behavioral support.
Yet the real-world picture is complicated. Many smokers who begin vaping do not fully switch away from cigarettes. Instead, they become dual users, continuing to smoke while also vaping. In those cases, the potential benefits of harm reduction may be smaller than originally hoped.
Another area of uncertainty involves cancer risk. At present, there is no direct evidence linking vaping to cancer in humans. However, the absence of proof does not necessarily mean the risk does not exist. Smoking-related cancers took decades to appear clearly in population studies. Laboratory experiments have already shown that e-cigarette vapor can cause DNA damage and cell death in cultured cells, patterns that resemble early findings in tobacco research many decades ago.
This long timeline is one reason why scientists are increasingly cautious about drawing firm conclusions. Widespread vaping is barely fifteen years old—far too short a period to observe diseases that may take decades to develop.
The key lesson emerging from the research is simple but important: vaping may reduce some of the dangers associated with smoking, but it introduces new uncertainties and potential harms of its own. For smokers trying to quit, vaping may serve as a temporary bridge away from cigarettes. For people who have never smoked—especially teenagers—the risks may outweigh any potential benefits.
Public health has learned hard lessons from tobacco in the past. Early warnings about cigarettes were visible long before the full scale of smoking-related disease became undeniable. The challenge now is recognizing which warning signs matter—and acting on them before the consequences become much harder to ignore.
